Guan, J., Yang, Q., Chen, C., Wang, G., & Zhu, H. (2021). Prognostic value of low skeletal muscle mass in hepatocellular carcinoma patients treated with sorafenib or lenvatinib: A meta-analysis. EXCLI Journal, 20, 1–16. https://doi.org/10.17179/excli2020-3111